Reducing Counterfeit Medicines Through Intelligent Packaging

Reducing Counterfeit Medicines Through Intelligent Packaging

Print and packaging strategy becomes a core part of risk management

Counterfeit medicines remain one of the most serious and fast‑evolving threats to global healthcare. From falsified life‑saving therapies to sub‑potent over‑the‑counter products, illicit pharmaceuticals undermine patient safety, erode trust in brands and regulators, and place immense pressure on quality and packaging teams.

This is where print and packaging strategy becomes a core part of risk management. Intelligent packaging, combining advanced print technologies, material science, and digital connectivity, can transform a carton into an active line of defence that supports:

  • Regulatory compliance and inspection readiness 
  • Patient and healthcare‑professional confidence 
  • Traceability and authentication across the supply chain 
  • Early detection and deterrence of counterfeit activity 

Here we explore four key pillars of secure, intelligent pharmaceutical packaging: overt and covert security features, tamper‑evident design, forensic inks and microtext, and emerging digital watermarking and connected‑pack solutions – all underpinned by robust carton manufacturing and secure printing in a GMP‑aligned, ISO‑certified environment.

1. Overt vs Covert Security Features: A Layered Defence

In printed packaging, security features includes a combination of overt (visible) and covert (hidden or machine‑readable) elements integrated into cartons, leaflets or booklets.

Overt Security Features

Overt features are clearly visible to the naked eye and are designed to help patients, pharmacists and supply‑chain partners identify genuine products quickly. Common examples include:

  • Holographic foils and patches
  • Color‑shifting inks or foils
  • Complex graphic design and guilloché patterns
  • Registered embossing or debossing

For Packaging, Quality and Regulatory Managers, overt features serve two purposes: they make casual counterfeiting more difficult, and they give downstream stakeholders a straightforward way to perform a first‑line authenticity check without specialist equipment.

Covert Security Features

Covert features are not immediately visible or may require tools, specific light conditions, or data access to verify. Their primary role is to support brand owners, regulators and law enforcement in investigations and in high‑risk markets.

Examples include:

  • UV‑reactive and fluorescent elements
  • Covert microtext
  • Hidden images and latent features
  • Invisible security codes

By combining overt and covert features into the print design and carton structure, manufacturers can build a tiered authentication strategy: easy checks for front‑line staff and far more advanced methods for investigators and brand protection teams.

2. Tamper‑Evident Carton

Security features are only one side of the anti‑counterfeiting equation. Preventing or signalling unauthorised access to the product is equally important.

Tamper‑evident design focuses on making it obvious if a pack has been opened, altered, or resealed. This is a core regulatory expectation in many markets and a fundamental component of patient safety.

CartonLevel Tamper Evidence

For secondary pharmaceutical packaging, carton structures can be engineered to provide robust tamper‑evidence without compromising line efficiency. Common approaches include:

  • Tear‑off or frangible flaps
  • Integrated tear strips
  • Locking tabs and glued flaps
  • Perforated or die‑cut windows

These features are designed into the carton die‑cut profile and executed on high‑precision die‑cutting and gluing lines. Consistency is crucial: if tamper‑evident features behave unpredictably on the line, they risk either not functioning in the market or causing wastage and production delays.

3. Forensic Inks, Coin Reactive Ink, Fluorescent Inks and Microtext

Advances in ink chemistry and print technology have created a powerful toolkit of forensic features that can be incorporated into cartons and inserts without dramatically changing their appearance.

Coin Reactive Ink

Coin reactive ink is a specialised security ink that reveals hidden text or images when rubbed with a coin or similar metal object. Under normal conditions, the printed area may appear as a standard solid or flat tint. When mechanically activated:

  • The friction and pressure from the coin change the ink’s appearance, revealing a symbol, code or message. 
  • The revealed feature provides a simple low‑tech authentication step for pharmacists or quality teams. 

Because this effect is difficult to reproduce with standard inks or digital printing, coin reactive areas offer a practical deterrent against basic copying or scanning.

Fluorescent and UV‑Reactive Inks

Fluorescent and UV‑reactive inks remain a mainstay of secure printing. They can be formulated to respond to specific wavelengths and intensities, allowing very controlled verification:

  • Invisible UV inks
  • Coloured fluorescent inks
  • Multi‑spectral inks

In a GMP‑regulated, ISO‑certified print environment, these inks are managed under strict controls:

  • Segregated storage and handling 
  • Recorded batch numbers and usage 
  • Verified ink densities and registration through inline inspection where feasible 

This approach not only strengthens brand protection but also supports audit readiness, demonstrating that security features are consistently and correctly applied.

Microtext and Fine-Line Detailing

Microtext is a highly effective covert measure that harnesses the precision of modern lithographic and high‑resolution digital printing:

  • Text is printed at a size that appears as a solid line to the naked eye but becomes legible under magnification (for example, 0.5–1.0 pt). 
  • Microtext can contain product codes, batch identifiers, or brand‑specific phrases, integrated unobtrusively into artwork. 
  • Complex fine‑line patterns can also be used to resist high‑resolution scanning and copying.

When combined with inline inspection systems capable of verifying text quality, microtext becomes not only a security feature but also a quality measure, ensuring that each print run meets defined tolerances.

Colorman Ireland supports pharmaceutical companies in turning anti-counterfeiting strategy into practical, validated solutions. We work in close collaboration with packaging, quality and regulatory teams to help prevent counterfeit activity by:

  • Designing and manufacturing secure cartons and printed components 
  • Applying advanced print technologies 
  • Engineering robust tamper-evident carton structures 
  • Operating within a GMP-aligned, ISO-certified environment
  • Supporting risk-based packaging decisions

By involving Colorman Ireland early in the development process, pharmaceutical companies can validate feasibility, avoid late-stage redesigns, and ensure that anti-counterfeiting measures are not only effective in the market but also manufacturable, inspectable and compliant.

In an environment where counterfeit threats continue to evolve, Colorman Ireland helps clients stay ahead—transforming pharmaceutical packaging into an intelligent, reliable and trusted line of defence for patients, brands and regulators alike.